Investors

Introduction

Introduction

Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders. We are developing a portfolio of potential therapeutic solutions aiming to make a lasting positive impact for the hundreds of thousands of children and adults living with inner ear related disorders.

documentation

Corporate presentation

Download corporate presentation

Year :

Year :

Year :

Stock information

Market: Euronext Growth (IPO in 2015)
Code Isin: FR0012596468
Mnemonique: ALSEN

Share price

Analyst coverage

Bryan, Garnier & Co

Victor Floc’h

Chardan

Geulah Livshits

Kempen

René Wouters

Jefferies

Lucy Codrington